This hypothesis can explain how the expression of SIRT1 and cytoplasmic β-catenin is correlated in patients with gastric adenocarcinoma and how patients with SIRT1 and β-catenin have better survival rates. Here, SIRT1 is linked to gastric adenocarcinoma.